+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
From
From
Bleeding Disorder Diagnostics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bleeding Disorder Diagnostics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
From
Philippines Diabetes Care Devices Market Report and Forecast 2024-2032 - Product Thumbnail Image

Philippines Diabetes Care Devices Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 160 Pages
  • Philippines
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Monoclonal Antibodies (MAs) Market Report 2025 - Product Thumbnail Image

Monoclonal Antibodies (MAs) Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Insulin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Insulin Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
From
From
Endocrinology Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Endocrinology Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
From
Pen Needles Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Pen Needles Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator